Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Cladribine Tablets and Relapsing–Remitting...
Journal article

Cladribine Tablets and Relapsing–Remitting Multiple Sclerosis: A Pragmatic, Narrative Review of What Physicians Need to Know

Abstract

Immune reconstitution therapy (IRT) is an emerging management concept for multiple sclerosis, whereby a short course of treatment provides long-lasting suppression of disease activity. “Cladribine tablets 10 mg” refers to a total cumulative dose of cladribine given over 2 years (henceforth referred to as cladribine tablets 3.5 mg/kg); it is a relatively new treatment option that is hypothesised to act as an IRT acting preferentially on the …

Authors

AlJumah M; Alkhawajah MM; Qureshi S; Al-Thubaiti I; Ayoub O; Bohlega SA; Bushnag A; Cupler E; Daif A; El Boghdady A

Journal

Neurology and Therapy, Vol. 9, No. 1, pp. 11–23

Publisher

Springer Nature

Publication Date

6 2020

DOI

10.1007/s40120-020-00177-5

ISSN

2193-8253